Delivery Order SPE2DB22D2206-SPE2DB25FKB99
- Not listed
- The Defense Logistics Agency awarded a $17,104.98 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Mekinist 0.5 mg tablets (30-count units). This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 25, 2025, and represents a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical supply needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $19,341.02 on July 22, 2025, for the supply of Mekinist 2 mg tablets (30-count units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 12, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Mekinist 2 mg tablets (30-count units) valued at $9,670.51 with a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 25, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,670.51 on September 9, 2025, for the supply of Mekinist 2 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set to be completed by September 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $8.55K to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Mekinist 0.5 mg tablets (30-count units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 4, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Mekinist 0.5 mg tablets in quantities of 30s, with a contract ceiling value of $5,701.68 and an ultimate completion date of October 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Mekinist 2 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $9,670.51 and is scheduled for completion by August 26, 2025. The contract is not subject to any small business set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a $19.3K delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Mekinist 2 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of May 12, 2025, and performance based in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mekinist 2 mg tablets (30-count units) under a competitive procurement with no set-aside designation. The contract, valued at $19,341.02, is scheduled for completion by July 11, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Mekinist 2 mg tablets (30-count units) under a firm fixed price contract with a ceiling value of $37,133.84. This non-set-aside delivery order is scheduled for completion by August 4, 2025, and will be fulfilled from the contractor's corporate office in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy medication, indicating this...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKB99Delivery Order
The Defense Logistics Agency awarded a $17,104.98 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Mekinist 0.5 mg tablets (30-count units), with an ultimate completion date of October 16, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The Mekinist procurement supports the Defense Health Agency's pharmaceutical supply chain, which provides medications to military personnel, veterans, and other federal healthcare beneficiaries. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains a comprehensive portfolio of federal medical supply contracts with DLA, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The SPE2DX prime vendor contract serves as a critical global pharmaceutical support vehicle enabling AmerisourceBergen to fulfill diverse medical commodity requirements for military healthcare programs worldwide, with DLA Troop Support planning to establish successor Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.1k | 9/24/25 |